Condition

Alpha-mannosidosis

Endocrine, Nutritional and Metabolic Diseases

Alpha-mannosidosis is a rare inherited lysosomal storage disorder caused by mutations in the MAN2B1 gene, which makes the enzyme alpha-mannosidase. Without working enzyme, mannose-containing sugar chains build up inside lysosomes and damage cells in many organs and tissues. Affected people may have intellectual disability, distinctive facial features such as a large head and prominent forehead, and skeletal problems including reduced bone density. Other features include poor coordination, muscle weakness, hearing loss, cataracts, increased risk of infection and enlargement of the liver and spleen. Severity ranges from an early-onset form with rapid neurological decline to milder later-onset forms with survival into the fifties. It is estimated to affect about 1 in 500,000 people worldwide and is inherited in an autosomal recessive pattern.

Facts
Classification
Body System
Skeletal System 1
Body System
Nervous System 1
ICD-10 Chapter
IV: Endocrine, Nutritional and Metabolic Diseases 2
Communicable or Non-communicable
Non-Communicable 1
Transmission Route
Non-Transmissible 1
First Described
1967 3
Prevalence Band
Rare (Under 1 in 2000) 4
Causative Agent
Causative Agent (category)
Genetic / Hereditary 1
Connections

Treated By

Source Alpha-mannosidosis (MedlinePlus Genetics)
Sources
1. Alpha-mannosidosis (MedlinePlus Genetics)
  • Description
    The skeletal abnormalities that can occur in this disorder include reduced bone density (osteopenia)
  • Description [body-system]
    The disorder may appear in infancy with rapid progression and severe neurological deterioration.
  • Causes
    Mutations in the MAN2B1 gene cause alpha-mannosidosis.
  • Description [disease-category]
    Alpha-mannosidosis is a rare inherited disorder that causes problems in many organs and tissues of the body.
  • Inheritance
    This condition is inherited in an autosomal recessive pattern
  • Treated By: Hematopoietic Stem Cell Transplantation, sentence that names a treatment of the condition
    Available from http://www.ncbi.nlm.nih.gov/books/NBK1396/ Citation on PubMed Grewal SS, Shapiro EG, Krivit W, Charnas L, Lockman LA, Delaney KA, Davies SM, Wenger DA, Rimell FL, Abel S, Grovas AC, Orchard PJ, Wagner JE, Peters C. Effective treatment of alpha-mannosidosis by allogeneic hematopoietic stem cell transplantation.
View the Source
2. Orphanet (Orphadata): Orphadata: Rare diseases with ICD-10 and ICD-11 mappings (en_product1)
Orphanet (Orphadata)ICD-10 mapping of ORPHA 61; chapter derived from code E77.1 (WHO range E00-E90)
Quote, ICD-10 mapping of ORPHA 61; chapter derived from code E77.1 (WHO range E00-E90)
ICD-10 E77.1
View the Source
3. Alpha-mannosidosis (Wikipedia)
Lead
Quote, Lead
Alpha-mannosidosis is a lysosomal storage disorder, first described by Swedish physician Okerman in 1967.
View the Source
4. Orphadata (Orphanet): Orphadata epidemiology, ORPHAcode 61
Orphadata (Orphanet)Orphanet epidemiology, ORPHAcode 61
Quote, Orphanet epidemiology, ORPHAcode 61
"PrevalenceClass": "1-9 / 1 000 000", "PrevalenceGeographic": "Europe", "PrevalenceQualification": "Value and class", "PrevalenceType": "Point prevalence"
View the Source
Comments (0)
No comments yet. Be the first to share a thought.
Reader Challenges (0)
No disputes yet. Spotted an error or a better source? Open the first one.

Medicine Atlas

How Healing Is Practiced
Sign In
Text size
100%
Theme